22nd Century Group Inc (NYSEAMERICAN:XXII) Shorts Increased By 6.05%

June 29, 2018 - By Sarah Holford

22nd Century Group, Inc. (NYSEAMERICAN:XXII) Corporate Logo

During Q1 2018 the big money sentiment decreased to 2.1. That’s change of 1.54, from 2017Q4’s 3.64. 6 investors sold all, 14 reduced holdings as 22nd Century Group, Inc. ratio is negative. 24 grew holdings while 18 funds bought holdings. Funds hold 15.79 million shares thus 46.81% less from 2017Q4’s 29.69 million shares.
Barclays Public Limited Co stated it has 108,802 shs. The Iowa-based Cambridge Inv Research Advsrs Inc has invested 0% in 22nd Century Group, Inc. (NYSEAMERICAN:XXII). Charter Trust Communications invested 0.02% of its capital in 22nd Century Group, Inc. (NYSEAMERICAN:XXII). Morgan Stanley, a New York-based fund reported 221,773 shs. Goldman Sachs Grp Inc Inc owns 828,103 shs. Sandler Mgmt holds 328,160 shs or 0.09% of its capital. Tci Wealth Advisors Inc reported 1,288 shs stake. Ameriprise Financial accumulated 0% or 32,935 shs. Pnc Svcs Group Inc holds 101,974 shs or 0% of its capital. Group One Trading L P stated it has 0.01% in 22nd Century Group, Inc. (NYSEAMERICAN:XXII). Geode Capital Limited Liability holds 662,362 shs or 0% of its capital. Captrust Fin holds 0% or 2,000 shs in its capital. Natl Bank Of Montreal Can invested in 0% or 112,300 shs. Bluefin Trading Limited Liability Com reported 26,706 shs. New York-based Jane Street Gp Limited Liability Com has invested 0% in 22nd Century Group, Inc. (NYSEAMERICAN:XXII).

22nd Century Group Inc (NYSEAMERICAN:XXII) had an increase of its shorted shares by 6.05%. FINRA issued shorted shares of XXII’s total 12.23 million shares. Previously was reported up change of 6.05% from 11.53M shares. 8 days will cost XXII with 1.50M average volume to recover its former position. 22nd Century Group Inc’s shorted shares float is 12.32%.

Ticker’s shares touched $2.51 during the last trading session after 0.40% change.Currently 22nd Century Group, Inc. is uptrending after 51.45% change in last June 29, 2017. XXII has also 878,361 shares volume. XXII outperformed by 38.88% the S&P500.

22nd Century Group, Inc., a plant biotechnology company, provides technology that allows for the level of nicotine and other nicotinic alkaloids in tobacco plants to be decreased or increased through genetic engineering and plant breeding.The firm is valued at $312.02 million. It develops smoking cessation products and modified risk tobacco products for smokers who are unable or unwilling to quit smoking and who may be interested in cigarettes, which reduce exposure to nicotine or to certain tobacco smoke toxins and/or pose a lower health risk than conventional cigarettes.Currently it has negative earnings. The company??s products include RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government research cigarettes.

22nd Century Group, Inc. (NYSEAMERICAN:XXII) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.